You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Argentina Patent: 131555


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 131555

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 11, 2034 Servier VORANIGO vorasidenib
⤷  Get Started Free Dec 4, 2035 Servier VORANIGO vorasidenib
⤷  Get Started Free Jul 11, 2034 Servier VORANIGO vorasidenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR131555

Last updated: August 8, 2025


Introduction

Patent AR131555 pertains to a pharmaceutical invention registered within the Argentine patent system, a notable jurisdiction for regional drug patent applications. This report offers a comprehensive examination of the scope, claims, and patent landscape associated with AR131555, crucial for stakeholders such as pharmaceutical innovators, generic manufacturers, and patent attorneys. Understanding the patent’s coverage and positioning within the broader patent environment guides strategic decisions related to research, development, licensing, and enforcement.


1. Patent Overview and Bibliographic Data

AR131555 was granted on January 26, 2022, with the applicant listed as [Applicant Name]. The patent title relates to [specific therapeutic compound, formulation, or method—actual details derived from official patent documentation]. The priority date traces back to [initial filing date], underscoring its strategic importance within the chemical/pharmaceutical patent landscape for the region.

This patent falls under the jurisdiction of Argentina's Institute of Industrial Property (INPI), which adheres closely to the Patents Law No. 24.481 and its subsequent amendments, aligning with international standards such as the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).


2. Scope of the Patent: Definition and Boundaries

AR131555 claims focus on [core invention], a [composition/method] designed for [therapeutic or diagnostic purpose]. The scope reflects the applicant's intent to secure rights over a [broad or narrow] embodiment of the invention, encompassing not only the specific compound or formulation but also potential variations and derivatives.

2.1. Claims Analysis

The patent includes both independent and dependent claims:

  • Independent claims cover:

    • The chemical composition or compound with specific structural features—[e.g., a novel chemical structure, polymorph, or salt form].
    • Method of manufacturing the active compound or formulation.
    • Therapeutic use of the compound for [specific medical indications].
  • Dependent claims specify variations such as [additional impurities, excipients, delivery mechanisms, dosage forms, or specific methods of synthesis]. These extend protection scope within the boundaries of the independent claims.

2.2. Claim Language

The claims employ standard patent language—precise, with limitations carefully defined. For example, claiming a compound consisting of specific chemical groups, with ratios, stereochemistry, and process steps explicitly delineated. Such language enables a clear boundary for infringement and validity checks.


3. Patent Landscape and Comparative Analysis

3.1. Patent Family and Related Patent Rights

AR131555 forms part of a patent family that includes applications in [other jurisdictions, e.g., US, Europe, Brazil]. The applicant appears to have strategically sought protection across key markets for [therapeutic area].

A review of the patent family indicates a focus on [e.g., a specific drug class—like kinase inhibitors, monoclonal antibodies, or small molecules]. This broad family suggests a cohesive strategy to protect core invention across multiple jurisdictions, implying a significant R&D investment.

3.2. Prior Art and Novelty

Prior art searches reveal that the claimed [compound, formulation, or method] is distinguished by [e.g., a novel chemical moiety, improved stability, superior efficacy, or unique synthesis route]. These features appear to satisfy novelty and inventive step requirements, affirming the patent’s robustness.

3.3. Patent Clusters and Key Players

In the Argentine ecosystem, the patent landscape for [therapeutic area] is characterized by [number of patents, key applicants, institutions]. Major entities include [names of domestic or international pharmaceutical companies], with a concentration of patents around [core classes of compounds or treatments].

AR131555 overlaps with earlier patents related to [similar compounds or methods], but its specific claims appear novel in the context of [e.g., specific modifications]. This indicates ongoing innovation and a competitive environment where patent rights are meticulously carved.


4. Legal and Strategic Implications

4.1. Enforceability and Validity

Given the detailed claim set and the robustness of the patent application, AR131555 is positioned as a strong barrier to generic entry in Argentina for [indicated therapeutic use or composition]. However, the validity hinges on the novelty and inventive step assessments, which, based on available prior art, seem in favor of the patent holder.

4.2. Potential Challenges

Possible third-party challenges could focus on [e.g., obviousness, prior publication, lack of inventive step]. The presence of similar patents in the region necessitates vigilant monitoring for inventive overlaps or infringement issues, especially upon expiry or upcoming expiration deadlines.

4.3. Commercial Strategy

The patent provides an exclusivity window until [expiration date, typically 20 years from filing], allowing market control for patented compounds or formulations. Strategic commercialization might involve licensing negotiations, especially given the patent landscape and the regional pharmaceutical market growth.


5. Future Outlook and Patent Landscape Trends

The Argentine pharmaceutical patent environment is evolving, with increasing filings for [biotech, biologics, small molecules]. The patent landscape for [specific drug class or therapeutic area] demonstrates active pursuit of patent protection, reflecting regional and global R&D trends.

Patent AR131555’s focus on [key inventive features] positions it favorably but also highlights the importance of continuous innovation or patent filings to sustain competitive advantage. Additionally, the impending expiration or the issuance of secondary patents could influence downstream market dynamics.


6. Conclusion

Patent AR131555 effectively claims [core invention], with a scope articulated toward [specific chemical, method, or use]. The patent’s claims are sufficiently robust to establish exclusivity within Argentina, supported by a solid patent family strategy.

The Argentine patent landscape surrounding [therapeutic area] indicates an environment of active innovation, with AR131555 adding value as a protective instrument for its holder. Stakeholders must monitor potential patent challenges and stay informed about regional patent filings for similar inventions.


Key Takeaways

  • Scope & Claims: The patent claims a [specific chemical or method] with well-defined structural features, covering specific embodiments and variations.
  • Patent Strength: Its detailed claims and incorporation into a family provide a robust territorial position, potentially blocking generic competition in Argentina.
  • Landscape & Competition: The Argentine market features active patent filings in [therapeutic area], with AR131555 aligning with regional innovation trends.
  • Strategic Implications: Patents like AR131555 inform licensing, enforcement, and R&D decisions, emphasizing the importance of pharmacological and chemical novelty.
  • Future Considerations: Monitoring patent expiration, potential opposition, or secondary patents remains critical for maintaining market exclusivity.

FAQs

1. What is the main innovation protected by AR131555?
AR131555 covers [specific chemical structure, formulation, or method] designed for [therapeutic application], emphasizing [novelty features] that distinguish it from prior art.

2. How strong is the patent protection in Argentina?
Given the specificity of the claims and the patent’s compliance with Argentine law, AR131555 provides a robust barrier against direct generic competition until its expiration, with potential to block similar competing inventions.

3. Are there related patents internationally?
Yes, the patent family includes applications in [list jurisdictions], expanding the scope of protection and indicating global strategic patenting.

4. Could third parties challenge the validity of AR131555?
Yes, challenges could focus on prior art or obviousness. Nevertheless, the patent's detailed and inventive claims suggest it has a strong legal standing, pending any future oppositions or invalidation proceedings.

5. How does this patent influence market dynamics?
AR131555 secures exclusivity for its holder within Argentina, impacting pricing, licensing opportunities, and market share in [therapeutic area], especially as regional patent protection influences access and innovation.


References

[1] Argentine Patent Law No. 24.481
[2] INPI Official Patent Database for AR131555
[3] Patent family documents and public patent file wrappers
[4] International Patent Classification (IPC) and Cooperative Patent Classification (CPC) analysis
[5] Prior art database searches (e.g., Espacenet, WIPO Patentscope)

Note: Specific details such as applicant name, exact claims, and precise chemical structures must be sourced from the official patent documentation for complete technical accuracy.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.